TCL Archive NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials. May 4, 2001
TCL Archive Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief. December 19, 2008
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: Let Salaries Rise To Legal Levels, Biomedical Panel Says; Prostatic Cancer Blood Test Found July 9, 1976
TCL Archive In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting November 14, 1975
